NRx Pharmaceuticals (Nasdaq: NRXP) subsidiary HOPE Therapeutics has acquired Dura Medical, a provider of interventional psychiatry services. Founded in 2018, Dura Medical has locations in Naples and Ft. Myers, Florida. The provider offers a number of interventions, including ketamine infusion therapy, transcranial magnetic stimulation (TMS), Spravato, as well as traditional psychiatry and therapy, according to a press release. HOPE Therapeutics, a clinical care delivery service, revealed that this deal is part of a larger M&A effort by the company, which includes the pending acquisitions of Neurospa TMS, and Cohen and Associates.
Read the full article: HOPE Therapeutics Acquires Dura Medical, Signals Continued Mental Health Consolidation //
Source: https://bhbusiness.com/2025/09/08/hope-therapeutics-acquires-dura-medical-signals-continued-mental-health-consolidation/